OpenAlex
PricingAboutJobs
Log inGet started
Work

Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma

HTML

Year: 2013
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-13-1825
Authors: Akito Nakamura, Takeo Arita, Shuntarou Tsuchiya, Jill Donelan, Jouhara Chouitar, Elizabeth Carideo, Katherine Galvin, Masanori Okaniwa, Tomoyasu Ishikawa, Sei Yoshida
Institution: Takeda (Japan)
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: pan-RAF inhibitor, melanoma, BRAF inhibitor resistance, NRAS-mutant melanoma, BRAF-mutant melanoma, RAF dimerization, MAPK signaling, vemurafenib, dabrafenib, MEK inhibitors, drug synergy, antiproliferative activity
SDG: Good health and well-being

Open Access status: closed

Funder: Takeda Pharmaceutical Company
OpenAlex ID: W1980427440
FWCI: 3.45
Cites: 49
Cited by: 131
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security